These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7191463)

  • 21. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of ovulation in the rat by an orally active antagonist of luteinizing hormone-releasing hormone.
    Nekola MB; Horvath A; Ge LJ; Coy DH; Schally AV
    Science; 1982 Oct; 218(4568):160-2. PubMed ID: 6750790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide.
    Bivens CH; Lebovitz HE; Feldman JM
    N Engl J Med; 1973 Aug; 289(5):236-9. PubMed ID: 4713762
    [No Abstract]   [Full Text] [Related]  

  • 24. A possible interaction of quipazine with central dopamine structures.
    Grabowska M; Antkiewicz L; Michaluk J
    J Pharm Pharmacol; 1974 Jan; 26(1):74-6. PubMed ID: 4150944
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotonin-like actions of quipazine and CPP on spinal motoneurones.
    Neuman RS; White SR
    Eur J Pharmacol; 1982 Jun; 81(1):49-56. PubMed ID: 7117370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of proestrous LH surge and ovulation in rats evoked by stimulation of the medial raphe nucleus involves a GABA-mediated mechanism.
    Morello H; Caligaris L; Haymal B; Taleisnik S
    Neuroendocrinology; 1989 Jul; 50(1):81-7. PubMed ID: 2666873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyproheptadine stimulated prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; el Halawani ME
    Poult Sci; 1985 May; 64(5):1038-40. PubMed ID: 3158889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A serotonin agonist-antagonist reversible effect on Na+-K+-ATPase activity in the developing rat brain.
    Hernández RJ
    Dev Neurosci; 1982; 5(4):326-31. PubMed ID: 6291893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head twitches induced by LSD and quipazine: similarities and differences.
    Vetulani J; Bednarczyk B; Reichenberg K; Rokosz A
    Neuropharmacology; 1980 Feb; 19(2):155-8. PubMed ID: 6244515
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonergic 5HT2 receptors mediate the inhibitory action of serotonin on luteinizing hormone secretion in ovariectomized, estradiol-treated ewes that are refractory to short days.
    Le Corre S; Chemineau P
    Biol Reprod; 1993 Jul; 49(1):140-7. PubMed ID: 8353180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of growth hormone release by intraventricular administration of 5HT or quipazine in unanesthetized male rats.
    Vijayan E; Krulich L; McCann SM
    Proc Soc Exp Biol Med; 1978 Nov; 159(2):210-2. PubMed ID: 714947
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotonergic influences on pituitary gland and hypothalamic induction of prolactin and luteinizing hormone release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; el Halawani ME
    Biol Reprod; 1985 Dec; 33(5):1064-72. PubMed ID: 4074804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamine stereotypy in cats and neurotransmitter interactions in the caudate nucleus. III. Effects of intracaudate injections of quipazine, cyproheptadine and electrical stimulation of the raphe dorsal nucleus.
    Moyanova SG; Rousseva SP
    Acta Physiol Pharmacol Bulg; 1989; 15(3):43-9. PubMed ID: 2574932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradoxical effects of drugs acting on the central nervous system on the preovulatory release of pituitary luteinizing hormone in pro-oestrous rats.
    Blake CA
    J Endocrinol; 1978 Dec; 79(3):319-26. PubMed ID: 570588
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of quipazine on the turnover rate of serotonin.
    Grabowska M; Antkiewicz L; Michaluk J
    Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by delta 1-tetrahydrocannabinol.
    Nir I; Ayalon D; Tsafriri A; Cordova T; Lindner HR
    Nature; 1973 Jun; 243(5408):470-1. PubMed ID: 4582754
    [No Abstract]   [Full Text] [Related]  

  • 38. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent inhibition of the preovulatory surges of gonadotropins and prolactin by the antiestrogen CI-628: possible sites of action.
    De Paolo LV
    Biol Reprod; 1985 May; 32(4):745-52. PubMed ID: 3924129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonergic mediation of a negative feedback effect of estrogen on luteinizing hormone release in ovariectomized rats.
    Johnson JH; Kitts CS
    Endocrinology; 1988 Nov; 123(5):2270-5. PubMed ID: 3168923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.